who is a candidate for glp-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1 Candidates: Are You Eligible

This is consistent with the FDA-approved label

As for clinical outcomes, in the T2DM group, there was a significant reduction in HbA1c (decreased by 1.01% to 1.02%, placebo-adjusted) and a clinically meaningful decrease in body weight of 3.26% to 3.51% after 12 weeks of treatment

Quick Answer: GLP-1 medications may help some women with PMOS, formerly known as PCOS, especially when insulin resistance, higher weight, prediabetes, type 2 diabetes, androgen excess, or cardiometabolic risk are part of the picture

When considering which GLP-1 medication is best for you, the cost is a significant factor to explore

doi: 10.2337/dc18-S008 21 ShiLJiYJiangXZhouLXuYLiYet al